Merck KGaA MKGAY Company Overview  Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Merck KGaA MKGAY Company Overview 

Stock Message Board http://investorshangout.com/search?q=MKGAY&am...mp;yt1=Go!

Merck KGaA MKGAY Current Price and Quotes
Last Price 49.79
Previous Close 49.1315 Open 49.71
Daily Range 49.79 - 49.61 52wk Range 56.04 - 40.20
Volume 526 Dividend 0.4996
Average Vol (3m) 26,581 Yield 1.0034
Merck KGaA MKGAY
Company Information

Frankfurter Strasse 250
Darmstadt 64293
Germany

Website: http://www.merck.de/en/index.html
Phone: 49-6151-72-0
Email: investor.relations@merck.de

Merck KGaA MKGAY
Merck KGaA is a global pharmaceutical, chemical and life science company with a history that began in 1668 and a future shaped by approximately 40,000 employees in 67 countries. Merck KGaA's subsidiaries in North America operate using the umbrella brand "EMD".

Merck KGaA MKGAY
Financial Reportings and Disclosures

Reporting Status International Reporting: Frankfurt Stock Exchange
CIK 0001004059
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Germany
Year of Inc. 1827
Employees Not Available
Company Officers/Contacts

Karl-Ludwig Kle Kley CEO
Matthias Zachert CFO
Constantin Fest IR
Company Directors

Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Merck KGaA MKGAY
MKGAY Security Details Other Company Securities

Share Structure

Market Value1 $9,653,422,037 a/o Sep 13, 2013
Shares Outstanding 64,621,120 a/o Jul 21, 2011
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.49959) Apr 24, 2013 Apr 26, 2013 May 14, 2013
Dividend (0.49079) Apr 24, 2013 Apr 26, 2013 May 14, 2013
Dividend (0.43612) Apr 18, 2012 Apr 20, 2012 May 08, 2012
Non US Stock Exchange Listing

MRK - Frankfurt Stock Exchange - Qualified
Short Selling Data

Short Interest 320 (-11.85%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

BNY Mellon

Merck KGaA MKGAY Recent News

Sept 10, 2013 EMD Serono Chief Financial Officer Named to South Shore Hospital Board of Directors
Sept 5, 2013 United States : Immunovaccine Announces Management Team Changes
Sept 3, 2013 Apitope Announces Positive Results from Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Aug 30, 2013 EMD Serono President and Head of US Operations James Hoyes Resigns
Aug 29, 2013 ObsEva SA announces CHF 32 Million Series A funding from leading Venture Capital firms and a license agreement with Merck Serono
Aug 8, 2013 Threshold Pharmaceuticals Initiates Phase 2 Study of TH-302 in Patients With Advanced Melanoma
Jul 24, 2013 Merck KGaA Receives Approval for Trademark CHROMOCULT
Jul 16, 2013 Life Technologies to Collaborate with Merck Serono for Companion Diagnostics Development and Commercialization
Jul 11, 2013 150 Cyclists from EMD Millipore and EMD Serono Participated in 150 Mile Ride for MS
Jul 9, 2013 Commitment of EUR4 Million Made to the Grant for Fertility Innovation (GFI) for the Years 2013 / 2014

1
2
next >

Merck KGaA MKGAY Financials
MKGAY


MKGAY Merck KGaA Research DD Guide

MKGAY Merck KGaA Stock Message Board http://investorshangout.com/search?q=MKGAY&am...mp;yt0=Go!
MKGAY Merck KGaA Stock Quote http://www.otcmarkets.com/stock/MKGAY/quote
MKGAY Merck KGaA Stock Chart http://www.otcmarkets.com/stock/MKGAY/chart
MKGAY Merck KGaA Company Info http://www.otcmarkets.com/stock/MKGAY/company-info
MKGAY Merck KGaA Recent News http://www.otcmarkets.com/stock/MKGAY/news
MKGAY Merck KGaA Financials http://www.otcmarkets.com/stock/MKGAY/financials
MKGAY Merck KGaA Filings and Disclosure http://www.otcmarkets.com/stock/MKGAY/filings
MKGAY Merck KGaA Short Sales http://www.otcmarkets.com/stock/MKGAY/short-sales
MKGAY Merck KGaA Insider Disclosure http://www.otcmarkets.com/stock/MKGAY/insider-transactions
MKGAY Merck KGaA Research Reports http://www.otcmarkets.com/stock/MKGAY/research
MKGAY Merck KGaA Summary http://finance.yahoo.com/q?s=MKGAY
MKGAY Merck KGaA Historical Prices http://finance.yahoo.com/q/hp?s=MKGAY+Historical+Prices
MKGAY Merck KGaA Interactive Chart http://finance.yahoo.com/echarts?s=MKGAY
MKGAY Merck KGaA Basic Chart http://finance.yahoo.com/q/bc?s=MKGAY+Basic+Chart
MKGAY Merck KGaA Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=MKGAY+Basic+Tech.+Analysis
MKGAY Merck KGaA Headlines http://finance.yahoo.com/q/h?s=MKGAY+Headlines
MKGAY Merck KGaA Press Releases http://finance.yahoo.com/q/p?s=MKGAY+Press+Releases
MKGAY Merck KGaA Company Profile http://finance.yahoo.com/q/pr?s=MKGAY+Profile
MKGAY Merck KGaA Key Statistics http://finance.yahoo.com/q/ks?s=MKGAY+Key+Statistics
MKGAY Merck KGaA Industry http://finance.yahoo.com/q/in?s=MKGAY+Industry
MKGAY Merck KGaA Major Holders http://finance.yahoo.com/q/mh?s=MKGAY+Major+Holders
MKGAY Merck KGaA Insider Transactions http://finance.yahoo.com/q/it?s=MKGAY+Insider+Transactions
MKGAY Merck KGaA Insider Roster http://finance.yahoo.com/q/ir?s=MKGAY+Insider+Roster
MKGAY Merck KGaA Income Statement http://finance.yahoo.com/q/is?s=MKGAY
MKGAY Merck KGaA Balance Sheet http://finance.yahoo.com/q/bs?s=MKGAY
MKGAY Merck KGaA Cash Flow http://finance.yahoo.com/q/cf?s=MKGAY+Cash+Flow&annual
MKGAY Merck KGaA Nasdaq http://www.nasdaq.com/symbol/MKGAY
MKGAY Merck KGaA Market Watch http://www.marketwatch.com/investing/stock/MKGAY
MKGAY Merck KGaA Bloomberg http://www.bloomberg.com/quote/MKGAY:US
MKGAY Merck KGaA Morningstar http://quotes.morningstar.com/stock/s?t=MKGAY
MKGAY Merck KGaA Bussinessweek http://investing.businessweek.com/research/st...cker=MKGAY
MKGAY Merck KGaA Barchart http://www.barchart.com/quotes/stocks/MKGAY
MKGAY Merck KGaA OTC Short Report http://otcshortreport.com/index.php?index=MKGAY
MKGAY Merck KGaA Investopedia http://www.investopedia.com/markets/stocks/MKGAY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 272

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 238

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 12

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 315

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 286

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 83

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 110

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 183

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 0

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

Anytime Fitness Launches First Club in Dubai, UAE, Expanding Reach

Updated Category News Views 508

Anytime Fitness Sets Foot in Dubai with Grand Opening The new club in the Arjan district signifies a vital expansion of fitness services to the United Arab Emirates; members benefit from personalized wellness plans, state-of-the-art Technogym equipment, and SmartCoaching services available through the AF App. Purpose Brands LLC has announced the grand opening of its very...

Continue Reading
Crescent Biopharma's Strategic Partnership and Market Moves

Updated Category News Views 196

Crescent Biopharma's Recent Stock Activity Crescent Biopharma, Inc. (NASDAQ: CBIO) has been experiencing a notable fluctuation in its stock value lately. Shares initially showed a positive trend, indicating investor optimism following their recent announcement, but later reversed course and began to dip slightly. This change in trading comes as the company unveiled a...

Continue Reading
Investors Alert: Legal Developments for Snap Inc. Shareholders

Updated Category News Views 167

Important Update for Snap Inc. Shareholders If you have invested in Snap Inc. (NYSE: SNAP) and purchased shares in 2021 or earlier, there are significant legal developments that you should be aware of. A recent lawsuit is reportedly pending, and the Shareholders Foundation has urged impacted investors to take action. Details of the Lawsuit Against Snap Inc. The lawsuit...

Continue Reading
Understanding the Influence of Trump's Fiscal Policies on Debt

Updated Category News Views 493

Understanding the Influence of Trump's Fiscal Policies on Debt When it comes to government debt, being large isn't necessarily an advantage. Recent fiscal policies introduced by the Trump administration, including tariffs and the initiatives of the Department of Government Efficiency, aim to address the growing fiscal deficit. However, the overall effect may result in...

Continue Reading
Analyzing Sea's Short Interest Trends and Market Implications

Updated Category News Views 128

Understanding Sea's Short Interest Dynamics Sea's short percent of float has notably increased by 5.22% since the latest report. The company currently has 21.99 million shares sold short, which accounts for 7.46% of its total shares available for trading. Based on recent trading volumes, it would take an average of 5.24 days for traders to cover their short positions....

Continue Reading